Aims To systematically assess late outcomes of acute pulmonary embolism (PE) and to
investigate the clinical implications of post-PE impairment (PPEI) fulfilling prospectively …

The incidence of chronic thromboembolic pulmonary hypertension (CTEPH) after pulmonary
embolism (PE) is relevant for management decisions but is currently unknown. We …

Chronic thromboembolic pulmonary hypertension (CTEPH) has been estimated to occur in
0.1–0.5% of patients who survive a pulmonary embolism (PE), but more recent prospective …

Background Early identification and treatment of chronic thromboembolic pulmonary
hypertension (CTEPH) are critical to prevent disease progression. We determined the …

Chronic thromboembolic pulmonary hypertension (CTEPH) is the most severe long-term
complication of acute pulmonary embolism (PE). Untreated CTEPH is fatal, but, if diagnosed …

INTRODUCTION: Chronic thromboembolic pulmonary hypertension (CTEPH) is a life
threatening but often, by pulmonary endarterectomy, curable disease. The incidence of …

Essentials• Predicting chronic thromboembolic pulmonary hypertension (CTEPH) after
pulmonary embolism is hard.• We studied 772 patients with pulmonary embolism who were …

Study objective To assess the incidence of chronic thromboembolic pulmonary hypertension
(CTPH) after the first episode of objectively confirmed pulmonary embolism (PE). Design …

Chronic thromboembolic pulmonary hypertension (CTEPH) is a severe complication of
pulmonary embolism. Its incidence following pulmonary embolism is debated. Active …

INTRODUCTION: The true incidence of chronic thromboembolic pulmonary hypertension
(CTPH) remains a matter of debate. Symptomatic CTPH is probably more common than …